Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adjuvants, Immunologic | 34 | 2024 | 998 | 6.370 |
Why?
|
Vaccines | 29 | 2024 | 842 | 4.850 |
Why?
|
Immunity, Innate | 52 | 2025 | 3080 | 4.290 |
Why?
|
BCG Vaccine | 8 | 2022 | 381 | 3.940 |
Why?
|
Toll-Like Receptor 8 | 11 | 2024 | 98 | 3.860 |
Why?
|
Toll-Like Receptors | 28 | 2019 | 582 | 3.670 |
Why?
|
Toll-Like Receptor 7 | 8 | 2024 | 169 | 2.610 |
Why?
|
Blood Proteins | 23 | 2024 | 1191 | 2.460 |
Why?
|
Monocytes | 15 | 2024 | 2605 | 2.440 |
Why?
|
Infant, Newborn | 78 | 2024 | 26422 | 2.440 |
Why?
|
Cytokines | 37 | 2024 | 7453 | 1.920 |
Why?
|
Antimicrobial Cationic Peptides | 21 | 2018 | 352 | 1.910 |
Why?
|
Vaccination | 22 | 2024 | 3437 | 1.890 |
Why?
|
Viral Vaccines | 7 | 2024 | 596 | 1.860 |
Why?
|
Staphylococcus epidermidis | 8 | 2020 | 121 | 1.860 |
Why?
|
Fetal Blood | 13 | 2021 | 1361 | 1.690 |
Why?
|
Imidazoles | 9 | 2024 | 1169 | 1.680 |
Why?
|
Hepatitis B Vaccines | 4 | 2022 | 178 | 1.610 |
Why?
|
Pentoxifylline | 4 | 2020 | 53 | 1.490 |
Why?
|
Bell Palsy | 2 | 2021 | 39 | 1.440 |
Why?
|
Dendritic Cells | 11 | 2024 | 2747 | 1.430 |
Why?
|
Immune System | 8 | 2020 | 799 | 1.330 |
Why?
|
Immunization | 10 | 2022 | 1219 | 1.330 |
Why?
|
Quinolines | 5 | 2017 | 772 | 1.250 |
Why?
|
Respiratory Syncytial Virus, Human | 3 | 2022 | 149 | 1.230 |
Why?
|
Leukocytes, Mononuclear | 13 | 2024 | 1854 | 1.180 |
Why?
|
Immunologic Memory | 7 | 2021 | 1377 | 1.120 |
Why?
|
Endotoxins | 5 | 2013 | 519 | 1.100 |
Why?
|
Respiratory Syncytial Virus Infections | 3 | 2022 | 365 | 1.040 |
Why?
|
Leukocytes | 8 | 2019 | 2035 | 1.020 |
Why?
|
Lipopolysaccharides | 10 | 2019 | 2219 | 0.990 |
Why?
|
Bacteremia | 7 | 2015 | 986 | 0.950 |
Why?
|
Communicable Diseases | 4 | 2024 | 874 | 0.940 |
Why?
|
Infant, Premature | 8 | 2020 | 2124 | 0.920 |
Why?
|
Th1 Cells | 3 | 2024 | 1042 | 0.900 |
Why?
|
Toll-Like Receptor 2 | 5 | 2015 | 348 | 0.890 |
Why?
|
Adenosine | 4 | 2013 | 820 | 0.890 |
Why?
|
Inflammasomes | 4 | 2018 | 540 | 0.880 |
Why?
|
Blood Bactericidal Activity | 8 | 2005 | 124 | 0.880 |
Why?
|
Adaptive Immunity | 5 | 2020 | 733 | 0.880 |
Why?
|
Aging | 8 | 2018 | 8744 | 0.880 |
Why?
|
Immunization Schedule | 2 | 2020 | 228 | 0.800 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 37 | 0.790 |
Why?
|
Alkaline Phosphatase | 2 | 2017 | 863 | 0.790 |
Why?
|
Adenosine Deaminase | 4 | 2024 | 253 | 0.780 |
Why?
|
Shoulder Dislocation | 3 | 2020 | 129 | 0.770 |
Why?
|
Gentamicins | 2 | 2020 | 244 | 0.750 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2023 | 4352 | 0.740 |
Why?
|
Inflammation Mediators | 5 | 2020 | 1892 | 0.730 |
Why?
|
Shoulder Joint | 9 | 2011 | 746 | 0.720 |
Why?
|
Fentanyl | 4 | 2024 | 451 | 0.710 |
Why?
|
Mandatory Programs | 1 | 2021 | 86 | 0.700 |
Why?
|
Neutrophils | 11 | 2024 | 3786 | 0.700 |
Why?
|
Anti-Inflammatory Agents | 4 | 2020 | 1805 | 0.680 |
Why?
|
Humans | 195 | 2025 | 768166 | 0.680 |
Why?
|
Antibody Formation | 3 | 2022 | 1393 | 0.680 |
Why?
|
Mass Vaccination | 1 | 2021 | 111 | 0.660 |
Why?
|
Animals, Newborn | 13 | 2020 | 2678 | 0.660 |
Why?
|
Antigen-Presenting Cells | 4 | 2020 | 960 | 0.640 |
Why?
|
Caspase 1 | 3 | 2018 | 227 | 0.640 |
Why?
|
Vancomycin | 2 | 2020 | 506 | 0.630 |
Why?
|
Staphylococcal Infections | 5 | 2020 | 1398 | 0.620 |
Why?
|
Microbial Viability | 1 | 2020 | 237 | 0.620 |
Why?
|
B-Lymphocytes | 8 | 2024 | 4793 | 0.610 |
Why?
|
Membrane Proteins | 14 | 2007 | 7876 | 0.610 |
Why?
|
Cathelicidins | 1 | 2018 | 81 | 0.600 |
Why?
|
Legionnaires' Disease | 1 | 2018 | 50 | 0.600 |
Why?
|
RNA, Bacterial | 1 | 2020 | 393 | 0.590 |
Why?
|
Legionella pneumophila | 1 | 2018 | 50 | 0.590 |
Why?
|
Immunity, Humoral | 4 | 2024 | 610 | 0.590 |
Why?
|
Disease Susceptibility | 4 | 2017 | 1793 | 0.590 |
Why?
|
Bacterial Infections | 7 | 2013 | 1397 | 0.570 |
Why?
|
Infant | 30 | 2024 | 36535 | 0.570 |
Why?
|
Shoulder Fractures | 2 | 2020 | 93 | 0.560 |
Why?
|
Mannose-Binding Lectin | 1 | 2018 | 146 | 0.560 |
Why?
|
Lectins, C-Type | 3 | 2022 | 594 | 0.550 |
Why?
|
Antibodies, Viral | 11 | 2025 | 3216 | 0.530 |
Why?
|
Proteomics | 10 | 2024 | 3912 | 0.530 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2016 | 705 | 0.530 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2016 | 113 | 0.530 |
Why?
|
Toll-Like Receptor 4 | 6 | 2012 | 588 | 0.520 |
Why?
|
Hepatitis | 1 | 2018 | 227 | 0.520 |
Why?
|
Acute-Phase Proteins | 4 | 2020 | 252 | 0.520 |
Why?
|
Animals | 65 | 2024 | 169246 | 0.510 |
Why?
|
Proteome | 5 | 2024 | 1890 | 0.510 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2018 | 235 | 0.500 |
Why?
|
Vaccines, Conjugate | 1 | 2017 | 334 | 0.490 |
Why?
|
Staphylococcus | 2 | 2013 | 146 | 0.490 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2011 | 238 | 0.490 |
Why?
|
Immunity | 6 | 2023 | 1003 | 0.490 |
Why?
|
Sepsis | 6 | 2020 | 2608 | 0.490 |
Why?
|
5'-Nucleotidase | 2 | 2013 | 164 | 0.480 |
Why?
|
B-Lymphocyte Subsets | 1 | 2016 | 241 | 0.480 |
Why?
|
Trachea | 2 | 2012 | 1095 | 0.480 |
Why?
|
Membrane Glycoproteins | 9 | 2013 | 3711 | 0.470 |
Why?
|
Poliovirus Vaccine, Oral | 2 | 2016 | 24 | 0.470 |
Why?
|
Receptors, Immunologic | 4 | 2019 | 1418 | 0.460 |
Why?
|
Anti-Infective Agents | 6 | 2018 | 983 | 0.450 |
Why?
|
Hypersensitivity | 2 | 2021 | 1172 | 0.440 |
Why?
|
Arthroplasty, Replacement | 4 | 2005 | 311 | 0.440 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 213 | 0.430 |
Why?
|
Organophosphorus Compounds | 1 | 2014 | 211 | 0.430 |
Why?
|
Pneumococcal Vaccines | 1 | 2017 | 414 | 0.420 |
Why?
|
RNA, Messenger | 12 | 2024 | 12800 | 0.420 |
Why?
|
Candida albicans | 3 | 2022 | 375 | 0.410 |
Why?
|
Inflammation | 9 | 2022 | 10873 | 0.410 |
Why?
|
Nanoparticles | 3 | 2024 | 1985 | 0.410 |
Why?
|
Immunocompromised Host | 2 | 2011 | 863 | 0.410 |
Why?
|
Chemokines | 7 | 2025 | 963 | 0.400 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2020 | 2538 | 0.400 |
Why?
|
Pyrimidines | 1 | 2024 | 3048 | 0.390 |
Why?
|
Bacterial Vaccines | 2 | 2017 | 400 | 0.390 |
Why?
|
S100 Proteins | 1 | 2012 | 216 | 0.390 |
Why?
|
Receptors, Cell Surface | 5 | 2019 | 2819 | 0.390 |
Why?
|
Adult | 55 | 2025 | 223646 | 0.380 |
Why?
|
Clavicle | 2 | 2005 | 224 | 0.380 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 234 | 0.380 |
Why?
|
Interleukin-6 | 7 | 2023 | 3228 | 0.380 |
Why?
|
Fibromyalgia | 1 | 2016 | 407 | 0.370 |
Why?
|
Endotoxemia | 3 | 2011 | 198 | 0.370 |
Why?
|
Immunologic Factors | 2 | 2013 | 1596 | 0.370 |
Why?
|
Benzazepines | 1 | 2013 | 308 | 0.360 |
Why?
|
Polymers | 2 | 2017 | 1630 | 0.360 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 128 | 0.360 |
Why?
|
Th2 Cells | 1 | 2016 | 1078 | 0.350 |
Why?
|
Immunity, Maternally-Acquired | 2 | 2010 | 112 | 0.350 |
Why?
|
Alum Compounds | 3 | 2016 | 35 | 0.350 |
Why?
|
Arthroscopy | 4 | 2016 | 971 | 0.350 |
Why?
|
Whooping Cough | 2 | 2022 | 87 | 0.350 |
Why?
|
Complement System Proteins | 3 | 2020 | 738 | 0.340 |
Why?
|
Mice, Inbred BALB C | 6 | 2024 | 6231 | 0.340 |
Why?
|
United States Food and Drug Administration | 4 | 2022 | 1673 | 0.340 |
Why?
|
Age Factors | 17 | 2024 | 18412 | 0.340 |
Why?
|
Drug Design | 2 | 2013 | 1046 | 0.340 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4415 | 0.340 |
Why?
|
Accessory Nerve Diseases | 1 | 2009 | 2 | 0.330 |
Why?
|
Communicable Disease Control | 3 | 2015 | 857 | 0.330 |
Why?
|
Fluoroquinolones | 1 | 2011 | 309 | 0.330 |
Why?
|
Escherichia coli | 5 | 2020 | 4214 | 0.330 |
Why?
|
NF-kappa B | 5 | 2024 | 2493 | 0.330 |
Why?
|
Homeostasis | 1 | 2020 | 3348 | 0.330 |
Why?
|
Mucous Membrane | 3 | 2008 | 659 | 0.330 |
Why?
|
Tuberculosis Vaccines | 1 | 2009 | 48 | 0.320 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2257 | 0.320 |
Why?
|
Tuberculosis | 1 | 2022 | 2029 | 0.320 |
Why?
|
Mice | 33 | 2024 | 82029 | 0.320 |
Why?
|
Interleukin-12 | 3 | 2024 | 577 | 0.320 |
Why?
|
Rheumatic Diseases | 1 | 2016 | 659 | 0.320 |
Why?
|
Cells, Cultured | 11 | 2020 | 19015 | 0.320 |
Why?
|
Fatigue | 1 | 2016 | 1557 | 0.310 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 1169 | 0.310 |
Why?
|
Defensins | 4 | 2002 | 35 | 0.310 |
Why?
|
Female | 73 | 2025 | 397192 | 0.310 |
Why?
|
AIDS Vaccines | 3 | 2019 | 900 | 0.310 |
Why?
|
Mice, Inbred C57BL | 14 | 2024 | 22379 | 0.310 |
Why?
|
Cell Movement | 1 | 2020 | 5210 | 0.310 |
Why?
|
Brain Injuries | 3 | 2020 | 2057 | 0.310 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4427 | 0.300 |
Why?
|
Energy Metabolism | 1 | 2019 | 2907 | 0.300 |
Why?
|
Plasma | 3 | 2021 | 585 | 0.300 |
Why?
|
Gambia | 5 | 2024 | 104 | 0.300 |
Why?
|
Vulnerable Populations | 2 | 2024 | 718 | 0.300 |
Why?
|
Recombinant Proteins | 8 | 2018 | 6514 | 0.290 |
Why?
|
Exercise Therapy | 2 | 2020 | 939 | 0.290 |
Why?
|
Paralysis | 1 | 2009 | 250 | 0.290 |
Why?
|
Scapula | 1 | 2009 | 175 | 0.290 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2185 | 0.280 |
Why?
|
Vaccines, DNA | 1 | 2008 | 279 | 0.280 |
Why?
|
Ventilators, Mechanical | 1 | 2009 | 292 | 0.280 |
Why?
|
Blood Loss, Surgical | 1 | 2011 | 642 | 0.280 |
Why?
|
Receptor, Adenosine A3 | 1 | 2006 | 4 | 0.280 |
Why?
|
Attitude | 2 | 2022 | 771 | 0.270 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3740 | 0.270 |
Why?
|
Virus Diseases | 2 | 2013 | 724 | 0.270 |
Why?
|
Colony Count, Microbial | 2 | 2018 | 328 | 0.270 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2020 | 359 | 0.260 |
Why?
|
Male | 58 | 2025 | 364719 | 0.260 |
Why?
|
Immunity, Cellular | 5 | 2024 | 1561 | 0.260 |
Why?
|
Signal Transduction | 14 | 2020 | 23645 | 0.250 |
Why?
|
Immunization Programs | 4 | 2019 | 267 | 0.250 |
Why?
|
Aluminum Hydroxide | 2 | 2022 | 55 | 0.250 |
Why?
|
Chemokine CCL2 | 2 | 2020 | 605 | 0.250 |
Why?
|
Pseudarthrosis | 1 | 2005 | 54 | 0.240 |
Why?
|
Cyclic AMP | 3 | 2019 | 1470 | 0.240 |
Why?
|
Phosphates | 2 | 2020 | 765 | 0.240 |
Why?
|
Anti-Bacterial Agents | 9 | 2020 | 7477 | 0.240 |
Why?
|
Babesiosis | 1 | 2006 | 92 | 0.240 |
Why?
|
Lipid A | 2 | 2016 | 70 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2024 | 3814 | 0.230 |
Why?
|
Aminoquinolines | 1 | 2004 | 105 | 0.230 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2013 | 5717 | 0.230 |
Why?
|
Docosahexaenoic Acids | 1 | 2011 | 914 | 0.230 |
Why?
|
Models, Biological | 1 | 2020 | 9495 | 0.230 |
Why?
|
Radiation Injuries | 1 | 2011 | 1198 | 0.230 |
Why?
|
Immunomodulation | 3 | 2021 | 549 | 0.230 |
Why?
|
Flagellin | 2 | 2020 | 124 | 0.230 |
Why?
|
Chickenpox Vaccine | 1 | 2003 | 39 | 0.220 |
Why?
|
Breast Feeding | 2 | 2024 | 1363 | 0.220 |
Why?
|
Cross-Priming | 1 | 2024 | 75 | 0.220 |
Why?
|
Muscle, Skeletal | 2 | 2009 | 4978 | 0.220 |
Why?
|
Pain | 3 | 2022 | 5100 | 0.220 |
Why?
|
Infant, Premature, Diseases | 2 | 2007 | 712 | 0.220 |
Why?
|
Lipoproteins | 2 | 2006 | 880 | 0.210 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2009 | 716 | 0.210 |
Why?
|
Pertussis Vaccine | 2 | 2022 | 39 | 0.210 |
Why?
|
Physical Examination | 1 | 2009 | 1263 | 0.210 |
Why?
|
Biomedical Research | 1 | 2018 | 3463 | 0.210 |
Why?
|
Escherichia coli Infections | 2 | 2020 | 524 | 0.200 |
Why?
|
Herpesvirus 3, Human | 1 | 2003 | 159 | 0.200 |
Why?
|
West Nile Fever | 1 | 2022 | 77 | 0.200 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3833 | 0.200 |
Why?
|
West Nile virus | 1 | 2022 | 77 | 0.200 |
Why?
|
Hemagglutinins | 1 | 2022 | 111 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2024 | 1656 | 0.200 |
Why?
|
Viral Fusion Proteins | 1 | 2022 | 100 | 0.200 |
Why?
|
HIV Infections | 7 | 2023 | 17569 | 0.200 |
Why?
|
Pregnancy | 13 | 2023 | 30256 | 0.200 |
Why?
|
Body Fluids | 1 | 2024 | 321 | 0.200 |
Why?
|
Streptococcus agalactiae | 1 | 2003 | 337 | 0.190 |
Why?
|
Mannans | 1 | 2022 | 58 | 0.190 |
Why?
|
Proteins | 4 | 2023 | 6009 | 0.190 |
Why?
|
Immunization, Secondary | 1 | 2024 | 373 | 0.190 |
Why?
|
Up-Regulation | 4 | 2020 | 4146 | 0.190 |
Why?
|
Bone Marrow | 1 | 2011 | 2935 | 0.190 |
Why?
|
Systems Biology | 3 | 2022 | 482 | 0.190 |
Why?
|
Immune Tolerance | 3 | 2012 | 2323 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 16045 | 0.190 |
Why?
|
Antigens, Viral | 2 | 2022 | 995 | 0.190 |
Why?
|
Gram-Negative Bacteria | 2 | 2000 | 275 | 0.180 |
Why?
|
Macrophages | 4 | 2022 | 5799 | 0.180 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2002 | 175 | 0.180 |
Why?
|
Antibodies | 2 | 2024 | 2421 | 0.180 |
Why?
|
Herpes Zoster | 1 | 2003 | 252 | 0.180 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2726 | 0.180 |
Why?
|
Humerus | 2 | 2017 | 273 | 0.180 |
Why?
|
Epithelial Cells | 5 | 2011 | 3703 | 0.180 |
Why?
|
HIV-1 | 5 | 2022 | 6961 | 0.180 |
Why?
|
Gestational Age | 3 | 2019 | 3621 | 0.180 |
Why?
|
Deltoid Muscle | 1 | 2020 | 19 | 0.180 |
Why?
|
Acyclovir | 1 | 2021 | 267 | 0.180 |
Why?
|
Public-Private Sector Partnerships | 1 | 2021 | 123 | 0.180 |
Why?
|
Bulgaria | 1 | 2020 | 17 | 0.170 |
Why?
|
Opioid-Related Disorders | 3 | 2024 | 2188 | 0.170 |
Why?
|
Toll-Like Receptor 9 | 2 | 2024 | 199 | 0.170 |
Why?
|
Severity of Illness Index | 6 | 2024 | 15948 | 0.170 |
Why?
|
Toll-Like Receptor 5 | 1 | 2020 | 42 | 0.170 |
Why?
|
DNA Methylation | 2 | 2024 | 4428 | 0.170 |
Why?
|
Vaccines, Attenuated | 2 | 2016 | 314 | 0.170 |
Why?
|
Phagocytosis | 5 | 2012 | 1530 | 0.170 |
Why?
|
Bottle Feeding | 1 | 2019 | 67 | 0.170 |
Why?
|
Prosthesis Design | 4 | 2017 | 2125 | 0.170 |
Why?
|
Chromatography, Liquid | 3 | 2022 | 996 | 0.170 |
Why?
|
Fetus | 1 | 2007 | 1883 | 0.170 |
Why?
|
Osteoarthritis | 2 | 2005 | 1072 | 0.160 |
Why?
|
Education | 2 | 2019 | 533 | 0.160 |
Why?
|
Lymphocyte Activation | 4 | 2021 | 5505 | 0.160 |
Why?
|
Mycobacterium bovis | 1 | 2020 | 148 | 0.160 |
Why?
|
United States | 10 | 2024 | 73039 | 0.160 |
Why?
|
Candidiasis | 1 | 2002 | 367 | 0.160 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 2 | 2010 | 75 | 0.160 |
Why?
|
Papua New Guinea | 3 | 2024 | 47 | 0.160 |
Why?
|
Interleukin-10 | 2 | 2017 | 1183 | 0.160 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1494 | 0.160 |
Why?
|
Virulence Factors, Bordetella | 1 | 2018 | 154 | 0.160 |
Why?
|
Congresses as Topic | 3 | 2019 | 812 | 0.160 |
Why?
|
Antibodies, Neutralizing | 4 | 2023 | 2011 | 0.160 |
Why?
|
Adolescent | 20 | 2024 | 89169 | 0.160 |
Why?
|
Killer Cells, Natural | 2 | 2009 | 2211 | 0.160 |
Why?
|
Immunophenotyping | 2 | 2020 | 1864 | 0.150 |
Why?
|
Carrier Proteins | 3 | 2013 | 4937 | 0.150 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2018 | 43 | 0.150 |
Why?
|
Child | 15 | 2024 | 80917 | 0.150 |
Why?
|
Chorioamnionitis | 1 | 2019 | 156 | 0.150 |
Why?
|
Fimbriae Proteins | 1 | 2018 | 133 | 0.150 |
Why?
|
Shoulder | 1 | 2020 | 300 | 0.150 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2012 | 582 | 0.150 |
Why?
|
Interdisciplinary Studies | 1 | 2018 | 86 | 0.150 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2008 | 549 | 0.150 |
Why?
|
Infant Formula | 1 | 2019 | 194 | 0.150 |
Why?
|
Blood Cells | 2 | 2015 | 309 | 0.150 |
Why?
|
Aged | 23 | 2025 | 171504 | 0.150 |
Why?
|
Child Development | 2 | 2020 | 2330 | 0.150 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2018 | 1245 | 0.150 |
Why?
|
Macaca mulatta | 2 | 2017 | 2363 | 0.150 |
Why?
|
RNA | 1 | 2007 | 2720 | 0.150 |
Why?
|
Flow Cytometry | 5 | 2024 | 5902 | 0.150 |
Why?
|
Tissue Culture Techniques | 1 | 2018 | 290 | 0.140 |
Why?
|
Denmark | 1 | 2020 | 776 | 0.140 |
Why?
|
Rosaniline Dyes | 1 | 2017 | 50 | 0.140 |
Why?
|
T-Lymphocytes | 5 | 2024 | 10266 | 0.140 |
Why?
|
Immunoglobulins | 1 | 2020 | 855 | 0.140 |
Why?
|
Fracture Fixation, Internal | 2 | 2020 | 982 | 0.140 |
Why?
|
Term Birth | 1 | 2018 | 140 | 0.140 |
Why?
|
Premature Birth | 2 | 2020 | 1829 | 0.140 |
Why?
|
Cell Wall | 1 | 2020 | 421 | 0.140 |
Why?
|
Histocytochemistry | 1 | 2018 | 699 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4648 | 0.140 |
Why?
|
Azithromycin | 1 | 2018 | 201 | 0.140 |
Why?
|
Salmonella | 1 | 2017 | 125 | 0.140 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2004 | 862 | 0.140 |
Why?
|
Lyme Disease | 1 | 2022 | 630 | 0.130 |
Why?
|
Nutritive Value | 1 | 2019 | 351 | 0.130 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 439 | 0.130 |
Why?
|
Lymphocytes | 1 | 2024 | 2614 | 0.130 |
Why?
|
Israel | 2 | 2016 | 726 | 0.130 |
Why?
|
Drug Synergism | 2 | 2018 | 1760 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 1014 | 0.130 |
Why?
|
Poliovirus Vaccine, Inactivated | 1 | 2016 | 24 | 0.130 |
Why?
|
HIV Seropositivity | 1 | 2022 | 966 | 0.130 |
Why?
|
Enzyme Assays | 1 | 2017 | 103 | 0.130 |
Why?
|
Drug Discovery | 1 | 2024 | 1068 | 0.130 |
Why?
|
Lactoferrin | 2 | 2013 | 100 | 0.130 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2016 | 126 | 0.130 |
Why?
|
Metabolomics | 3 | 2020 | 1674 | 0.130 |
Why?
|
Malaria Vaccines | 1 | 2017 | 165 | 0.130 |
Why?
|
Vaccines, Synthetic | 3 | 2024 | 622 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2020 | 906 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1281 | 0.130 |
Why?
|
Ectodermal Dysplasia | 2 | 2008 | 107 | 0.130 |
Why?
|
Range of Motion, Articular | 4 | 2008 | 1597 | 0.130 |
Why?
|
Biomimetics | 1 | 2017 | 172 | 0.130 |
Why?
|
Gene Expression Profiling | 4 | 2025 | 9538 | 0.130 |
Why?
|
Vaccines, Inactivated | 1 | 2016 | 186 | 0.130 |
Why?
|
HIV Antibodies | 2 | 2019 | 1341 | 0.130 |
Why?
|
Japan | 1 | 2020 | 1418 | 0.120 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2015 | 59 | 0.120 |
Why?
|
Poliomyelitis | 1 | 2016 | 91 | 0.120 |
Why?
|
Lipoxins | 2 | 2011 | 419 | 0.120 |
Why?
|
Young Adult | 11 | 2024 | 60066 | 0.120 |
Why?
|
Klebsiella pneumoniae | 1 | 2017 | 253 | 0.120 |
Why?
|
Milk, Human | 1 | 2019 | 490 | 0.120 |
Why?
|
Chemokine CXCL1 | 1 | 2015 | 102 | 0.120 |
Why?
|
Middle Aged | 22 | 2025 | 223492 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2015 | 4283 | 0.120 |
Why?
|
Asthma | 2 | 2024 | 6291 | 0.120 |
Why?
|
Myocarditis | 1 | 2022 | 802 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2002 | 2414 | 0.120 |
Why?
|
Organ Transplantation | 1 | 2025 | 1176 | 0.120 |
Why?
|
Immunoglobulin Class Switching | 1 | 2016 | 289 | 0.120 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4568 | 0.120 |
Why?
|
Systems Analysis | 1 | 2015 | 168 | 0.120 |
Why?
|
Quality of Life | 1 | 2016 | 13490 | 0.110 |
Why?
|
Lung | 3 | 2022 | 10099 | 0.110 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2709 | 0.110 |
Why?
|
Cell Adhesion Molecules | 2 | 2011 | 1613 | 0.110 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2014 | 23 | 0.110 |
Why?
|
Analysis of Variance | 2 | 2013 | 6229 | 0.110 |
Why?
|
Cell Adhesion | 1 | 2020 | 3096 | 0.110 |
Why?
|
Brain | 3 | 2020 | 27360 | 0.110 |
Why?
|
Radiography | 4 | 2013 | 6983 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1904 | 0.110 |
Why?
|
Enteral Nutrition | 1 | 2019 | 802 | 0.110 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2202 | 0.110 |
Why?
|
Influenza Vaccines | 1 | 2021 | 781 | 0.110 |
Why?
|
Pancreatectomy | 1 | 2018 | 825 | 0.110 |
Why?
|
India | 1 | 2020 | 2334 | 0.110 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1150 | 0.110 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2018 | 748 | 0.110 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 560 | 0.110 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 342 | 0.100 |
Why?
|
Limulus Test | 1 | 2012 | 19 | 0.100 |
Why?
|
Inosine | 1 | 2013 | 129 | 0.100 |
Why?
|
Interleukin-1beta | 2 | 2017 | 1027 | 0.100 |
Why?
|
Microscopy | 1 | 2018 | 909 | 0.100 |
Why?
|
Caspase 3 | 1 | 2015 | 730 | 0.100 |
Why?
|
Treatment Outcome | 10 | 2020 | 65371 | 0.100 |
Why?
|
Isoenzymes | 1 | 2017 | 1688 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1907 | 0.100 |
Why?
|
Vaccines, Subunit | 1 | 2012 | 159 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2018 | 3590 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6316 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 693 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 2016 | 2430 | 0.100 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2015 | 327 | 0.100 |
Why?
|
Mice, SCID | 1 | 2017 | 2627 | 0.100 |
Why?
|
Immunoglobulin M | 1 | 2016 | 1528 | 0.100 |
Why?
|
C-Reactive Protein | 1 | 2003 | 3858 | 0.100 |
Why?
|
Spleen | 2 | 2015 | 2295 | 0.090 |
Why?
|
Vaccines, Acellular | 2 | 2022 | 11 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18349 | 0.090 |
Why?
|
Drug Delivery Systems | 2 | 2020 | 2232 | 0.090 |
Why?
|
Interleukins | 1 | 2016 | 796 | 0.090 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2010 | 21 | 0.090 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 11928 | 0.090 |
Why?
|
Whole-Body Irradiation | 1 | 2011 | 435 | 0.090 |
Why?
|
Blood Cell Count | 1 | 2011 | 406 | 0.090 |
Why?
|
Cell Proliferation | 4 | 2016 | 10474 | 0.090 |
Why?
|
Genetic Testing | 1 | 2004 | 3591 | 0.090 |
Why?
|
Lipopeptides | 2 | 2011 | 71 | 0.090 |
Why?
|
Bacteriolysis | 1 | 2010 | 51 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2003 | 2062 | 0.090 |
Why?
|
Dexamethasone | 1 | 2018 | 1965 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 2004 | 0.090 |
Why?
|
Receptors, IgG | 1 | 2013 | 564 | 0.090 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1377 | 0.090 |
Why?
|
Electromyography | 2 | 2020 | 1401 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1430 | 0.090 |
Why?
|
I-kappa B Kinase | 2 | 2008 | 250 | 0.080 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 552 | 0.080 |
Why?
|
Organ Size | 2 | 2011 | 2267 | 0.080 |
Why?
|
Thoracic Nerves | 1 | 2009 | 20 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2016 | 2357 | 0.080 |
Why?
|
Hip Joint | 1 | 2016 | 1018 | 0.080 |
Why?
|
Liver | 3 | 2015 | 7577 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2023 | 3986 | 0.080 |
Why?
|
Phospholipids | 2 | 2008 | 787 | 0.080 |
Why?
|
Child, Preschool | 8 | 2024 | 42669 | 0.080 |
Why?
|
Blotting, Western | 2 | 2011 | 5027 | 0.080 |
Why?
|
Ligands | 3 | 2022 | 3284 | 0.080 |
Why?
|
Phenotype | 3 | 2024 | 16726 | 0.080 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3488 | 0.080 |
Why?
|
Ablation Techniques | 1 | 2011 | 255 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2271 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2014 | 1251 | 0.080 |
Why?
|
Computational Biology | 3 | 2024 | 3568 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6082 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2015 | 14488 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2004 | 3781 | 0.080 |
Why?
|
Crassostrea | 1 | 2007 | 1 | 0.080 |
Why?
|
Apyrase | 1 | 2011 | 376 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 859 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2009 | 1353 | 0.070 |
Why?
|
Oligopeptides | 2 | 2019 | 1194 | 0.070 |
Why?
|
Sampling Studies | 1 | 2009 | 615 | 0.070 |
Why?
|
Hematopoiesis | 2 | 2020 | 2059 | 0.070 |
Why?
|
Organ Specificity | 1 | 2012 | 1968 | 0.070 |
Why?
|
Blood | 1 | 2010 | 599 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10399 | 0.070 |
Why?
|
Genetic Diseases, X-Linked | 2 | 2008 | 386 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10840 | 0.070 |
Why?
|
Adenosine A3 Receptor Antagonists | 1 | 2006 | 2 | 0.070 |
Why?
|
Antigens, CD | 2 | 2011 | 4035 | 0.070 |
Why?
|
Rupture | 1 | 2008 | 444 | 0.070 |
Why?
|
Bursa, Synovial | 1 | 2006 | 24 | 0.070 |
Why?
|
Macrophage-1 Antigen | 2 | 2006 | 286 | 0.070 |
Why?
|
Shoulder Impingement Syndrome | 1 | 2006 | 35 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 40218 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2012 | 3610 | 0.070 |
Why?
|
Prognosis | 3 | 2024 | 30010 | 0.070 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14783 | 0.070 |
Why?
|
Neutropenia | 1 | 2011 | 892 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2008 | 18065 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6793 | 0.060 |
Why?
|
Sex Factors | 1 | 2020 | 10632 | 0.060 |
Why?
|
Babesia | 1 | 2006 | 29 | 0.060 |
Why?
|
Receptors, Virus | 1 | 2009 | 652 | 0.060 |
Why?
|
Pediatrics | 2 | 2024 | 3629 | 0.060 |
Why?
|
Neurologic Examination | 1 | 2009 | 914 | 0.060 |
Why?
|
Joint Instability | 2 | 2004 | 803 | 0.060 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 210 | 0.060 |
Why?
|
Thiazoles | 1 | 2013 | 1542 | 0.060 |
Why?
|
Peptides | 3 | 2009 | 4354 | 0.060 |
Why?
|
Models, Immunological | 1 | 2007 | 518 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9374 | 0.060 |
Why?
|
Polydeoxyribonucleotides | 1 | 2006 | 136 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 41754 | 0.060 |
Why?
|
Rotator Cuff | 1 | 2008 | 348 | 0.060 |
Why?
|
Lipids | 3 | 2024 | 3343 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2633 | 0.060 |
Why?
|
Interferon Inducers | 1 | 2004 | 24 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3803 | 0.060 |
Why?
|
Lymphocyte Subsets | 2 | 2009 | 313 | 0.060 |
Why?
|
Lymphoid Tissue | 1 | 2006 | 445 | 0.060 |
Why?
|
Myeloid Cells | 2 | 2007 | 839 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2024 | 3160 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10760 | 0.060 |
Why?
|
Pronation | 1 | 2004 | 52 | 0.060 |
Why?
|
Phosphorylation | 2 | 2006 | 8317 | 0.060 |
Why?
|
Safety | 1 | 2009 | 1159 | 0.060 |
Why?
|
Supination | 1 | 2004 | 70 | 0.060 |
Why?
|
Integrin alphaXbeta2 | 1 | 2003 | 29 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4580 | 0.060 |
Why?
|
Antirheumatic Agents | 1 | 2014 | 1381 | 0.060 |
Why?
|
Complement Factor B | 1 | 2003 | 57 | 0.060 |
Why?
|
Muscle Strength | 1 | 2008 | 640 | 0.060 |
Why?
|
Lipocalins | 1 | 2004 | 161 | 0.050 |
Why?
|
Muscle Contraction | 1 | 2008 | 1209 | 0.050 |
Why?
|
Host-Pathogen Interactions | 3 | 2020 | 1469 | 0.050 |
Why?
|
Prospective Studies | 6 | 2025 | 54926 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2006 | 557 | 0.050 |
Why?
|
Poverty | 1 | 2015 | 2720 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2862 | 0.050 |
Why?
|
Uterus | 1 | 2007 | 663 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15454 | 0.050 |
Why?
|
Equipment Design | 1 | 2011 | 3522 | 0.050 |
Why?
|
Dinoprostone | 2 | 2018 | 597 | 0.050 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2022 | 48 | 0.050 |
Why?
|
Intestinal Mucosa | 2 | 2011 | 3044 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3800 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 766 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 26379 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4206 | 0.050 |
Why?
|
Serum | 1 | 2003 | 206 | 0.050 |
Why?
|
Transcription Factor RelB | 1 | 2022 | 29 | 0.050 |
Why?
|
Bone Cements | 1 | 2004 | 327 | 0.050 |
Why?
|
Joint Prosthesis | 1 | 2004 | 251 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2011 | 2451 | 0.050 |
Why?
|
Rotation | 1 | 2004 | 517 | 0.050 |
Why?
|
Weight Gain | 1 | 2012 | 2359 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2022 | 977 | 0.050 |
Why?
|
Anti-Retroviral Agents | 2 | 2023 | 1789 | 0.050 |
Why?
|
Cell Extracts | 1 | 2002 | 135 | 0.050 |
Why?
|
Pneumococcal Infections | 1 | 2006 | 529 | 0.050 |
Why?
|
Amphotericin B | 1 | 2002 | 143 | 0.050 |
Why?
|
Complement C3 | 1 | 2003 | 434 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59629 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2009 | 1361 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5315 | 0.050 |
Why?
|
Ligaments, Articular | 1 | 2004 | 308 | 0.050 |
Why?
|
Plant Physiological Phenomena | 1 | 2000 | 16 | 0.050 |
Why?
|
beta-Glucans | 1 | 2022 | 129 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2023 | 390 | 0.050 |
Why?
|
Anura | 1 | 2000 | 79 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 486 | 0.050 |
Why?
|
Mutation | 5 | 2011 | 30238 | 0.050 |
Why?
|
Humeral Head | 1 | 2020 | 41 | 0.040 |
Why?
|
Sutures | 1 | 2003 | 282 | 0.040 |
Why?
|
Animal Experimentation | 1 | 2020 | 46 | 0.040 |
Why?
|
Liposomes | 1 | 2024 | 790 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2024 | 1609 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2002 | 330 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2004 | 717 | 0.040 |
Why?
|
Protein Conformation | 2 | 2009 | 3956 | 0.040 |
Why?
|
Solubility | 1 | 2022 | 1083 | 0.040 |
Why?
|
Genetic Diseases, Inborn | 1 | 2005 | 606 | 0.040 |
Why?
|
Arthroplasty | 1 | 2002 | 308 | 0.040 |
Why?
|
Clinical Trials as Topic | 3 | 2019 | 8054 | 0.040 |
Why?
|
Colitis | 1 | 2008 | 1242 | 0.040 |
Why?
|
Isometric Contraction | 1 | 2020 | 149 | 0.040 |
Why?
|
Toll-Like Receptor 3 | 2 | 2012 | 99 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2022 | 1065 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2830 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2015 | 11669 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2020 | 213 | 0.040 |
Why?
|
CpG Islands | 1 | 2024 | 1208 | 0.040 |
Why?
|
Accidents, Traffic | 1 | 2005 | 818 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2022 | 3474 | 0.040 |
Why?
|
Paranasal Sinuses | 1 | 2022 | 267 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12252 | 0.040 |
Why?
|
Diglycerides | 1 | 2019 | 176 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2002 | 640 | 0.040 |
Why?
|
HIV Seronegativity | 1 | 2020 | 210 | 0.040 |
Why?
|
Bordetella pertussis | 1 | 2018 | 45 | 0.040 |
Why?
|
Reoperation | 3 | 2004 | 4329 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10101 | 0.040 |
Why?
|
Genotype | 1 | 2013 | 13045 | 0.040 |
Why?
|
Belgium | 1 | 2018 | 119 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 535 | 0.040 |
Why?
|
Administration, Topical | 1 | 2000 | 703 | 0.040 |
Why?
|
Prosthesis Failure | 1 | 2004 | 1208 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7608 | 0.040 |
Why?
|
Protein Subunits | 1 | 2022 | 943 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 1966 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 485 | 0.040 |
Why?
|
Antibodies, Bacterial | 2 | 2018 | 1479 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 720 | 0.040 |
Why?
|
Prevalence | 2 | 2013 | 15869 | 0.040 |
Why?
|
Pandemics | 3 | 2022 | 8748 | 0.040 |
Why?
|
HLA Antigens | 1 | 2003 | 1334 | 0.040 |
Why?
|
Aerosols | 1 | 2000 | 634 | 0.040 |
Why?
|
Placenta | 1 | 2007 | 1725 | 0.040 |
Why?
|
Cell Membrane | 2 | 2004 | 3655 | 0.040 |
Why?
|
Antigens | 2 | 2016 | 1442 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5536 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2002 | 879 | 0.040 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 64 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2023 | 942 | 0.040 |
Why?
|
Suture Techniques | 1 | 2002 | 775 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2006 | 2568 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2020 | 631 | 0.040 |
Why?
|
Rabbits | 2 | 1994 | 4772 | 0.040 |
Why?
|
Analgesics, Opioid | 2 | 2024 | 3837 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2002 | 1836 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2023 | 924 | 0.030 |
Why?
|
DNA, Complementary | 2 | 2007 | 1989 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3628 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1918 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1057 | 0.030 |
Why?
|
DNA, Viral | 1 | 2003 | 2204 | 0.030 |
Why?
|
Immunity, Mucosal | 1 | 2020 | 498 | 0.030 |
Why?
|
Bacterial Proteins | 2 | 2006 | 3840 | 0.030 |
Why?
|
Disease Progression | 2 | 2024 | 13671 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2007 | 2748 | 0.030 |
Why?
|
Muramidase | 1 | 1996 | 163 | 0.030 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2018 | 404 | 0.030 |
Why?
|
Phospholipases A | 1 | 1996 | 204 | 0.030 |
Why?
|
Protein Binding | 3 | 2019 | 9343 | 0.030 |
Why?
|
Bone Transplantation | 1 | 2020 | 925 | 0.030 |
Why?
|
Interferon Type I | 2 | 2010 | 569 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2528 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 2002 | 1058 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1597 | 0.030 |
Why?
|
France | 1 | 2016 | 497 | 0.030 |
Why?
|
Reference Values | 1 | 2002 | 4938 | 0.030 |
Why?
|
Regeneration | 1 | 2004 | 1524 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2024 | 81762 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1886 | 0.030 |
Why?
|
Cell Separation | 1 | 1999 | 1728 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2872 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14729 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15832 | 0.030 |
Why?
|
Patient Positioning | 1 | 2016 | 332 | 0.030 |
Why?
|
Pain Measurement | 1 | 2004 | 3583 | 0.030 |
Why?
|
Models, Molecular | 1 | 2003 | 5403 | 0.030 |
Why?
|
Caco-2 Cells | 2 | 2005 | 366 | 0.030 |
Why?
|
Drug Substitution | 1 | 2016 | 291 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7951 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 860 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1815 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2120 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.030 |
Why?
|
Phylogeny | 1 | 2000 | 2843 | 0.030 |
Why?
|
Measles Vaccine | 1 | 2013 | 79 | 0.030 |
Why?
|
Drug Carriers | 1 | 2017 | 709 | 0.030 |
Why?
|
Viral Load | 1 | 2022 | 3396 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2007 | 13421 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4528 | 0.020 |
Why?
|
Patient Selection | 1 | 2004 | 4260 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2018 | 1197 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2007 | 17622 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2020 | 1903 | 0.020 |
Why?
|
Pancreatitis | 1 | 2018 | 1087 | 0.020 |
Why?
|
Cross Infection | 1 | 2020 | 1426 | 0.020 |
Why?
|
Carbohydrates | 1 | 2012 | 389 | 0.020 |
Why?
|
Mammals | 1 | 1996 | 1135 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2173 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1730 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3231 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3905 | 0.020 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2009 | 25 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22371 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2010 | 260 | 0.020 |
Why?
|
Cell Line | 3 | 2010 | 15597 | 0.020 |
Why?
|
Transfection | 2 | 2010 | 5755 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2002 | 3073 | 0.020 |
Why?
|
Purines | 1 | 2012 | 615 | 0.020 |
Why?
|
Clusterin | 1 | 2009 | 72 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1993 | 1534 | 0.020 |
Why?
|
STAT1 Transcription Factor | 1 | 2010 | 343 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1567 | 0.020 |
Why?
|
Granulocytes | 1 | 2010 | 551 | 0.020 |
Why?
|
Ostreidae | 1 | 2007 | 3 | 0.020 |
Why?
|
Risk Factors | 2 | 2013 | 74944 | 0.020 |
Why?
|
Coagulase | 1 | 2007 | 53 | 0.020 |
Why?
|
Down-Regulation | 2 | 2006 | 2937 | 0.020 |
Why?
|
Invertebrates | 1 | 2007 | 55 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4030 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4168 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2009 | 451 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2007 | 251 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 915 | 0.020 |
Why?
|
K562 Cells | 1 | 2008 | 644 | 0.020 |
Why?
|
Streptolysins | 1 | 2006 | 61 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2000 | 12465 | 0.020 |
Why?
|
Sp Transcription Factors | 1 | 2005 | 2 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 704 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3620 | 0.020 |
Why?
|
Peritonitis | 1 | 2008 | 368 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2007 | 571 | 0.020 |
Why?
|
Phagocytes | 1 | 2007 | 294 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2014 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1993 | 2094 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5995 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6430 | 0.020 |
Why?
|
Diet | 1 | 2023 | 8089 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12795 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2009 | 762 | 0.010 |
Why?
|
Siblings | 1 | 2008 | 828 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 287 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1750 | 0.010 |
Why?
|
Ethanol | 1 | 2010 | 1331 | 0.010 |
Why?
|
Binding Sites | 1 | 1993 | 6020 | 0.010 |
Why?
|
Hot Temperature | 1 | 2010 | 1441 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 1967 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5955 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2007 | 2179 | 0.010 |
Why?
|
Decidua | 1 | 2003 | 82 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5926 | 0.010 |
Why?
|
Apoptosis | 2 | 2011 | 9523 | 0.010 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2008 | 621 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3623 | 0.010 |
Why?
|
Acromioclavicular Joint | 1 | 2004 | 78 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8647 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2011 | 1726 | 0.010 |
Why?
|
Microglia | 1 | 2011 | 1376 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 866 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2003 | 1142 | 0.010 |
Why?
|
Allergens | 1 | 2009 | 1443 | 0.010 |
Why?
|
Learning | 1 | 2011 | 1759 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2006 | 764 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13090 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1435 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36743 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1683 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4833 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14164 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4539 | 0.010 |
Why?
|
Salmonella typhimurium | 1 | 2002 | 348 | 0.010 |
Why?
|
Cysteine | 1 | 2003 | 897 | 0.010 |
Why?
|
Hippocampus | 1 | 2011 | 3785 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3311 | 0.010 |
Why?
|
Protein Transport | 1 | 2002 | 1951 | 0.010 |
Why?
|
Treatment Failure | 1 | 2002 | 2661 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6124 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 5797 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2004 | 1279 | 0.010 |
Why?
|
Transcription Factors | 1 | 2011 | 12168 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9384 | 0.010 |
Why?
|
Rats | 1 | 2003 | 23760 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13676 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2002 | 39348 | 0.000 |
Why?
|